SEC Filing Summary: National Health Investors, Inc. (NHI)
Business Context and Reporting Period
This Form 8-K was filed by National Health Investors, Inc. on February 26, 2026. The filing serves as a Regulation FD disclosure to disseminate an investor presentation and a press release titled "NHI Issues Investor Update." The company is incorporated in Maryland and its common stock trades on the New York Stock Exchange under the symbol NHI.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for external materials (Exhibits 99.1 and 99.2) rather than containing the financial data itself.
Material Changes
No material changes to financial performance or operations are detailed within the text of this Form 8-K. The filing references an investor update but does not summarize the specific changes or comparisons to prior periods.
Guidance, Outlook, and Risks
Management commentary, guidance, and outlook are contained within the attached investor presentation (Exhibit 99.2) and press release (Exhibit 99.1), which are not included in the text of this filing. The filing explicitly states that the information in these exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific financial results and guidance by accessing the attached Exhibit 99.1 (Press Release) and Exhibit 99.2 (Investor Presentation) on the company's website or the SEC EDGAR database.
- Note that the information in the exhibits is not legally "filed" under Section 18 of the Exchange Act, which may affect liability standards for the statements made therein.
- Confirm the date of the investor update is February 26, 2026, as indicated in the filing.